Broadwater Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Hold
11,210
0.84% 28
2026
Q1
$890K Hold
11,210
0.66% 35
2025
Q4
$890K Hold
11,210
0.66% 35
2025
Q3
$845K Sell
11,210
-762,056
-99% -$52.2M 0.62% 37
2025
Q2
$773M Buy
773,266
+762,056
+6,798% +$50M 0.6% 39
2025
Q1
$759K Hold
11,210
0.59% 43
2024
Q4
$503K Sell
11,210
-5,566
-33% -$312K 0.39% 51
2024
Q3
$1.05M Hold
16,776
0.78% 35
2024
Q2
$991K Hold
16,776
0.76% 37
2024
Q1
$1.34M Sell
16,776
-5,900
-26% -$451K 1.03% 27
2023
Q4
$1.79M Buy
+22,676
New +$1.61M 1.4% 21

Other funds holding CVS

Broadwater Capital's CVS Position: Q2 2026 in Review

Broadwater Capital held its CVS Health (CVS) position steady in Q2 2026 at 11,210 shares worth $1.16M. The position accounts for 0.84% of the portfolio, ranked #28.

Broadwater Capital first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $773M in Q2 2025. 1,128 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Broadwater Capital held 11,210 shares of CVS Health worth $1.16M as of Q2 2026.
  • Broadwater Capital left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.84% of Broadwater Capital's portfolio in Q2 2026, its #28 holding.
  • Broadwater Capital first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • Broadwater Capital's CVS Health position peaked at $773M in Q2 2025.
  • 1,128 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Broadwater Capital's 13F filing for Q2 2026, filed 24 Jul 2026.